FDA Approves Nucala for Chronic Obstructive Pulmonary Disease
Approval is for adult patients with COPD with eosinophilic inflammation
Trend Toward Survival Benefit Seen for REM-Inhibition in ALS
REM inhibition via receipt of antidepressant medications associated with trend toward survival benefit
Pulmonary Embolism More Common in Children Than Previously Thought
Rates similar to adults presenting to the emergency department with symptoms
FDA and Border Officials Join Forces to Seize Vast Quantity of Illegal E-Cigarettes
Almost $34 million worth of unauthorized e-cigarette products seized in joint operation
Persistent, New Mucus Plugs Associated With Faster Decline in FEV1 in COPD
The steepest decrease in FEV1 seen for those with persistently positive mucus plugs who resume smoking
Combinations of Chronic, Physical Illnesses Up the Risk of Subsequent Depression
In the highest-risk groups, roughly one in 12 people developed depression over the next 10 years
FDA Limits COVID-19 Boosters to Seniors, Other High-Risk Groups
Accurate Risk Prediction Model Developed for Pediatric Pneumonia
Model can discriminate between mild community-acquired pneumonia and moderate or severe community-acquired pneumonia accurately
Methotrexate Noninferior to Prednisone in Pulmonary Sarcoidosis
Methotrexate noninferior to prednisone with regard to change from baseline to week 24 in percentage of predicted forced vital capacity
Wearable Sensor Can Monitor Sleep Apnea Treatment Response
A wearable pulse oximeter and connected software platform shows patient acceptability in ongoing trials
